Pacer Advisors, Inc. Spectrum Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$2.89 - $4.45 $39,506 - $60,831	-13,670 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$2.9 - $4.09 $1,566 - $2,208	540 Added 4.11%	13,670 $45,000
Q4 2020 Jan 20, 2021	BUY	$3.38 - $5.14 $23,734 - $36,093	7,022 Added 114.96%	13,130 $45,000
Q3 2020 Oct 19, 2020	BUY	$2.99 - $4.9 $18,262 - $29,929	6,108 New	6,108 $25,000
Q4 2018 Feb 13, 2019	SELL	$6.39 - $16.99 $76,673 - $203,863	-11,999 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $198,223 - $297,815	11,999 New	11,999 $202,000
Q1 2018 May 14, 2018	SELL	$16.09 - $23.07 $22,638 - $32,459	-1,407 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $18,797 - $29,167	1,407	1,407 $27,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.